Glycemic Exposure, Glycemic Control, and Metabolic Karma in Diabetic Complications

被引:25
作者
Thomas, Merlin C. [1 ,2 ]
机构
[1] Monash Univ, Baker IDI Heart & Diabet Inst, Melbourne, Vic 3004, Australia
[2] Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Vic 3004, Australia
关键词
Diabetes; Diabetic nephropathy; Legacy; Memory; Epigenetics; HISTONE LYSINE METHYLATION; GENOME-WIDE ANALYSIS; FASTING GLUCOSE; RETINOPATHY; DIMETHYLATION; NEPHROPATHY; EPIGENETICS; MORTALITY; MELLITUS; MEMORY;
D O I
10.1053/j.ackd.2014.03.004
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Diabetes continues to cast a long shadow over the lives of many people. It is now clear that even transient hyper- or hypoglycemia or increased glycemic variability around healthy mean glucose levels can have long-lasting and long-term effects on the development and progression of diabetic complications, including cardiovascular disease, kidney disease, retinopathy, and neuropathy. Even after glycemic control has been achieved and maintained for many years, it appears hard to undo the changes that are instilled, including epigenetic programming, compositional changes, post-translational modifications, or simply lead time toward an inevitable fate. This phenomenon has become known as "metabolic memory" or the "legacy effect," but it may be better characterized as "metabolic karma," in which the intent and actions of an individual (with respect to metabolic control) influence the future health of that individual. This "bad karma" has been used to explain many clinical observations surrounding diabetes and its management, including the lack of benefits in many short- and intermediate-term trials, and the potential utility of early intensive glycemic control. Further understanding the molecular basis of a metabolic legacy in diabetes will certainly provide new targets for intervention. (C) 2014 by the National Kidney Foundation, Inc. All rights reserved.
引用
收藏
页码:311 / 317
页数:7
相关论文
共 47 条
  • [1] [Anonymous], N ENGL J MED
  • [2] [Anonymous], J AM MED ASS
  • [3] [Anonymous], J AM MED ASS
  • [4] [Anonymous], NEW ENGL J MED
  • [5] [Anonymous], MEDICOGRAPHIA
  • [6] [Anonymous], N ENGL J MED
  • [7] [Anonymous], AM J OPHTHALMOL
  • [8] Telomere length predicts all-cause mortality in patients with type 1 diabetes
    Astrup, A. S.
    Tarnow, L.
    Jorsal, A.
    Lajer, M.
    Nzietchueng, R.
    Benetos, A.
    Rossing, P.
    Parving, H. -H.
    [J]. DIABETOLOGIA, 2010, 53 (01) : 45 - 48
  • [9] Risk of cardiovascular and all-cause mortality in individuals with diabetes mellitus, impaired fasting glucose, and impaired glucose tolerance - The Australian diabetes, obesity, and lifestyle study (AusDiab)
    Barr, Elizabeth L. M.
    Zimmet, Paul Z.
    Welborn, Timothy A.
    Jolley, Damien
    Magliano, Dianna J.
    Dunstan, David W.
    Cameron, Adrian J.
    Dwyer, Terry
    Taylor, Hugh R.
    Tonkin, Andrew M.
    Wong, Tien Y.
    McNeil, John
    Shaw, Jonathan E.
    [J]. CIRCULATION, 2007, 116 (02) : 151 - 157
  • [10] Bianchi Cristina, 2011, Rev Diabet Stud, V8, P432, DOI 10.1900/RDS.2011.8.432